Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase

https://policybase.cma.ca/link/policy11129
Date
2014-05-15
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13641
Date
2017-04-07
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts

https://policybase.cma.ca/link/policy13918
Date
2018-02-15
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Complementary and alternative medicine (update 2015)

https://policybase.cma.ca/link/policy11529
Date
2015-05-30
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Date
2015-05-30
Replaces
Complementary and alternative medicine (Update 2008)
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Consultation on proposed front-of-package labelling

https://policybase.cma.ca/link/policy13882
Date
2018-04-23
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the renewal of Federal Tobacco Control Strategy

https://policybase.cma.ca/link/policy13804
Date
2017-04-05
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada consultation on tobacco products regulations (plain and standardized appearance)

https://policybase.cma.ca/link/policy13930
Date
2018-09-06
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/link/policy13817
Date
2016-08-12
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Implementation of National Pharmacare

https://policybase.cma.ca/link/policy13933
Date
2018-10-02
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Insite: CMA submission regarding Insite supervised injection site and program.

https://policybase.cma.ca/link/policy14129
Date
2011-02-17
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/link/policy13802
Date
2016-10-31
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/link/policy11814
Date
2016-01-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

https://policybase.cma.ca/link/policy13936
Date
2016-10-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health
Health care and patient safety

Tamper Resistance under the Controlled Drugs and Substances Act

https://policybase.cma.ca/link/policy11295
Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs